The cells were administered i.t. between the 5th and 14th day of life without signs of dose-limiting toxicity or severe adverse effects.
There were no signs of dose-response relationships between alcohol consumption and future LBP.
A total of 15 patients received the complete treatment cycle of 10 days without showing signs of dose-limiting toxicity, whereas therapy in three patients was stopped on day 8 due to a grade 3 4 elevation of liver enzymes (alanine aminotransferase [ALT], aspartate aminotransferase [AST]) (Table 2).
Three of six patients at the dose of 350 mg m−2 of gemicitabine demonstrated dose-limiting toxicities involving neutropenia/ leukocytopenia and elevated transaminase, while nine patients at doses of 150 mg m−2 and 250 mg m−2 did not demonstrate any sign of dose-limiting toxicity.
Therapeutic administration of the selective agonist ERA-63 decreased the clinical signs of arthritis dose-dependently.
In this regard if, at the first reassessment (14 days), clinical response was deemed to be insufficient (e.g. poor weight gain, lack of resolution of clinical signs), the dose of enzyme was doubled.
Because the low dose improved transgene expression and had no signs of toxicity, this dose was used to evaluate the tumor targeting and biodistribution of SFV particles upon intraperitoneal (i.p. 1.8 × 10 v.p).
In the case of early signs of clotting, citrate dose was further adapted to aim for a postfilter ionized calcium of 0.25 to 0.3 mmol/L.
In fact, the rats in our study did not exhibit any overt signs of illness with doses of LVS as high as 107 CFU.
According to the opinion of DTU Food, the finding of reduced learning capacity of newborn males may be a sign of low-dose effect of BPA.
H&E staining of fixed lung sections from the different doses showed no signs of fibrosis at the low dose, very mild changes in the medium dose, and a similar extent and pattern of fibrosis as indicated in figure 3 for the high dose of 5 mg silica per mouse (Data not illustrated).
